Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trialDeepak L. Bhatt, Mark Napoli, Philippe Gabríel Steg et al.|The Lancet|2019Cited by 212
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studiesDavid T. Rubin, Patrick Chamouard, Hongyan Zhang et al.|The Lancet|2024Cited by 95
Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trialMillie Long, James Fon, Jessica R. Allegretti et al.|The Lancet. Gastroenterology & hepatology|2026Cited by 6
Invasive Infection of the Gastrointestinal Tract by Leishmania in Patients with AIDSMiguel Górgolas, Manuel L. Fernández-Guerrero, Elena Bello et al.|Infectious Diseases in Clinical Practice|1997Cited by 1